Clal Biotechnology Industries Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Clal Biotechnology Industries.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 37.3% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
The Market Doesn't Like What It Sees From Clal Biotechnology Industries Ltd.'s (TLV:CBI) Revenues Yet
Apr 18Calculating The Fair Value Of Clal Biotechnology Industries Ltd. (TLV:CBI)
Jul 14Does Clal Biotechnology Industries (TLV:CBI) Have A Healthy Balance Sheet?
Jan 19Investors Shouldn't Be Too Comfortable With Clal Biotechnology Industries' (TLV:CBI) Robust Earnings
Mar 25Clal Biotechnology Industries (TLV:CBI) Seems To Use Debt Quite Sensibly
Mar 24Introducing Clal Biotechnology Industries (TLV:CBI), The Stock That Zoomed 121% In The Last Year
Feb 16What Kind Of Shareholders Own Clal Biotechnology Industries Ltd. (TLV:CBI)?
Jan 12Is Clal Biotechnology Industries (TLV:CBI) Using Too Much Debt?
Dec 07In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Clal Biotechnology Industries has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 0 | -31 | -9 | -9 | N/A |
9/30/2023 | 0 | -20 | -9 | -9 | N/A |
6/30/2023 | 0 | -6 | -26 | -25 | N/A |
3/31/2023 | -14 | -7 | -46 | -45 | N/A |
12/31/2022 | 0 | -7 | -60 | -59 | N/A |
9/30/2022 | 77 | -78 | -71 | -70 | N/A |
6/30/2022 | 0 | -18 | -64 | -62 | N/A |
3/31/2022 | 72 | -86 | -47 | -46 | N/A |
12/31/2021 | 0 | -28 | -43 | -41 | N/A |
9/30/2021 | 22 | 103 | -44 | -42 | N/A |
6/30/2021 | 45 | 89 | -33 | -29 | N/A |
3/31/2021 | 79 | 109 | -39 | -36 | N/A |
12/31/2020 | 0 | 186 | -36 | -33 | N/A |
9/30/2020 | 72 | -41 | -31 | -28 | N/A |
6/30/2020 | 67 | -51 | -53 | -50 | N/A |
3/31/2020 | 127 | -144 | 18 | 20 | N/A |
12/31/2019 | 113 | -154 | 24 | 27 | N/A |
9/30/2019 | 98 | -114 | 22 | 24 | N/A |
6/30/2019 | 83 | -81 | 15 | 18 | N/A |
3/31/2019 | 12 | -32 | -73 | -70 | N/A |
12/31/2018 | 13 | -45 | -90 | -87 | N/A |
9/30/2018 | 10 | -68 | -101 | -98 | N/A |
6/30/2018 | 35 | -61 | -86 | -81 | N/A |
3/31/2018 | 36 | -36 | -83 | -79 | N/A |
12/31/2017 | 43 | -28 | -96 | -91 | N/A |
9/30/2017 | 47 | -122 | N/A | -89 | N/A |
6/30/2017 | 27 | -176 | N/A | -113 | N/A |
3/31/2017 | 30 | -209 | N/A | -110 | N/A |
12/31/2016 | 24 | -214 | N/A | -113 | N/A |
9/30/2016 | 22 | -149 | N/A | -118 | N/A |
6/30/2016 | 20 | -138 | N/A | -116 | N/A |
3/31/2016 | 20 | -113 | N/A | -142 | N/A |
12/31/2015 | 25 | -118 | N/A | -147 | N/A |
9/30/2015 | 45 | -350 | N/A | -129 | N/A |
6/30/2015 | 40 | -800 | N/A | -129 | N/A |
3/31/2015 | 33 | -747 | N/A | -120 | N/A |
12/31/2014 | 24 | -747 | N/A | -116 | N/A |
9/30/2014 | 2 | -518 | N/A | -155 | N/A |
6/30/2014 | 1 | -65 | N/A | -159 | N/A |
3/31/2014 | 2 | -123 | N/A | -156 | N/A |
12/31/2013 | 3 | -95 | N/A | -149 | N/A |
9/30/2013 | 6 | -58 | N/A | -128 | N/A |
6/30/2013 | 8 | -63 | N/A | -116 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if CBI's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if CBI's earnings are forecast to grow faster than the IL market
High Growth Earnings: Insufficient data to determine if CBI's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if CBI's revenue is forecast to grow faster than the IL market.
High Growth Revenue: Insufficient data to determine if CBI's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CBI's Return on Equity is forecast to be high in 3 years time